| 1038 Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.
1037 Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.
1036 Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
1035 Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
1034 Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.
1033 Transfer of pathogenic and nonpathogenic cytosolic proteins between spinal cord motor neurons in vivo in chimeric mice.
1032 Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease.
1031 Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease.
1030 Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior.
1029 Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.